.jpg)
Lab PI
I-Ying Kuo, Ph.D.
I am interested in study the tumor microenvironment, with a special focus on the interactions between tumor cells and immune cells.
More.
學歷 Education:
2007/09 ~ 2014/06 Institute of Basic Medical Science, National Cheng Kung University, Taiwan
2005/09 ~ 2007/09 Institute of Immunology, Chung-Shan Medical University, Taichung, Taiwan
經歷 Experience:
2022/08 ~ NOW Assistant Professor, Department of Biotechnology, Kaohsiung Medical University. Taiwan
2018/02 ~ 2022/06 Postdoctoral research fellow, Department of Pharmacology, National Cheng Kung University, Taiwan
2016/08 ~ 2017/08 Postdoctoral research fellow, Institute of Biological Chemistry, Academia Sinica, Taiwan
2014/09 ~ 2016/08 Postdoctoral research fellow, Liver Transplant Center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
2002/09 ~ 2005/09 Medical Technologist
專業訓練或證照 Licenses & Certifications:
Medical Technician, Ministry of Examination, Taiwan. Issued Jun 2000 · No Expiration Date
We interested in:
-
Epigenetic regulation of immune cell for phenotypic switch in TME.
-
Drug discovery in the epigenetic regulation and new light in epi-drugs combination with other immunotherapy.
-
Exploring the impact of air pollution factor (PM2.5) on the development of lung cancer and its preventive mechanisms within the population with metabolic diseases.
-
Studies on the Association Between ALDH2 Gene Variants and Alcohol Intolerance in Esophageal Squamous Cell Carcinoma (ESCC).
Meet our Team
Members
林品緣
Master student (MS)
Study topic:
Explore the BATF-mediated T cell exhaustion mechanism within CCR2+ T cell subsets in the lung cancer microenvironment.
吳政哲
College student: 4th
Study topic:
The role of FOXM1 in the Lung tumor microenvironment.
黃湘芸
College student: 3rd
Study topic:
Old drugs repurposed: The mechanism of action of niclosamide on cancer cells
吳品瑩
College student: 2nd
Study topic:
Exploring improvement strategies for PM2.5 air pollution factor in the metabolic disorders.
蘇容凡
College student: 2nd
Study topic:
Investigating the Mechanisms of the ALDH2 Gene in Esophageal Cancer